| Herbal Products and Hepatotoxicity in the Perspective of Cases | İçim GÖKKAYA,Gülin RENDA | 133–152 |
| Experimental Models in Neuroinflammatory Diseases: Systematic Review | Ömer BAHÇELİ,Şefika Pınar ŞENOL,Bahar TUNÇTAN | 153–165 |
| Trends in Generic Drug Use in Turkey and in the World | Dilara BAYRAM,Volkan AYDIN,Caner VIZDIKLAR,Ahmet AKICI | 166–175 |
| Immunotoxic Effects of Pesticides | Jülide SECERLİ,İlknur Sıla LEBLEBİCİ,Merve BACANLI,Onur ERDEM | 176–186 |
| COVID 19: Current Treatment Approaches and Evaluation of Their Toxicities | Ünzile SUR,Belma GÜMÜŞEL | 187–197 |
| New In Vitro Skin Tissue Models and Skin Substitutes | Sena ERKAN,Selinay Başak ERDEMLİ KÖSE,Suna SABUNCUOĞLU,Pınar ERKEKOĞLU | 198–210 |
| Pharmacovigilance System and the Role of Pharmacist: Systematic Review | Özge CEMİLOĞLU ÜLKER,Büşra ESEN | 211–222 |
| The Assessment of Multiple Organ Involvement Due to SARS-CoV-2: Traditional Review | Hande YÜCE,Songül ÜNÜVAR | 223–230 |
| Pharmacokinetic Alterations and Their Effects of Drug Dosing in Obese Children and Adolescents: Traditional Review | Aslınur ALBAYRAK,Bensu KARAHALİL | 231–240 |
| Bioactive Glasses from a Pharmaceutical Perspective: Systematic Reviews | Müge KILIÇARSLAN,Cemre Nur GENCEL | 241–256 |
| 1,25-Dihidroksikolekalsiferol: Metabolik Sendrom ve Obezite Üzerindeki Etkiler: Geleneksel Derleme | Hatice Tuğçe BERBEROĞLU,Aysun HACIŞEVKİ | 257–267 |
| 1,25-Dihydroxycholecalciferol:Effects on Metabolic Syndrome and Obesity: Traditional Review | Hatice Tuğçe BERBEROĞLU, Aysun HACIŞEVKİ | 257–267 |
| Antioxidant, Antimicrobial and Antidiabetic Properties of Stevia rebaudiana (Bertoni): Systematic Review | Zeynep KALAYCI,Hülya KAMARLI,Ahmet Yılmaz ÇOBAN | 268–275 |
| Postbiotics and Their Effects on Health: Systematic Review |